Rep. Richard McCormick Sells Medtronic (MDT) Stock in Roth IRA

A new filing under the STOCK Act shows Hon. Richard Dean Dr McCormick, a member of the U.S. House of Representatives, reported a sale of Medtronic plc Ordinary Shares (MDT) dated July 30, 2026. The transaction, valued between $1,001 and $15,000, was executed personally by the member and held through a Growth Partners Roth IRA, according to the periodic transaction report filed with the House.

Periodic Transaction Reports like this one are required within 45 days of a covered transaction under the STOCK Act, giving the public a window into the personal securities activity of lawmakers. The filing discloses only a value range rather than an exact dollar amount, which is standard practice for these disclosures. Nothing in the report indicates any wrongdoing or connects the sale to specific legislative activity; it simply documents a legally required disclosure of a personal financial transaction.

A Notable Timing Overlap

What makes this filing worth flagging is its proximity to another MDT-related transaction. Company insider Walter Matthew R. also sold Medtronic shares on July 31, 2026, just one day after Rep. McCormick’s reported sale date, in a transaction valued at $143,028. Both sales fall within the same 30-day window, which is the kind of overlap whoisbuyingnow.com tracks when monitoring clusters of activity around a single ticker. The two transactions are disclosed through entirely different reporting regimes — one a congressional STOCK Act filing, the other an insider transaction report — and there is no indication in either filing that the two are connected. Still, when a member of Congress and a company insider both sell shares of the same stock within a day of each other, it’s the kind of pattern that merits noting for readers following MDT closely.

Medtronic, a major medical device manufacturer, is a widely held stock across institutional and individual portfolios alike, so isolated trading activity — even from a lawmaker or insider — does not necessarily signal anything about the company’s underlying business or outlook. Readers interested in how larger institutional investors have been positioning around holdings like this may also want to see how professional money managers have shifted their portfolios; for a look at one such manager’s quarterly moves, see our coverage of Renaissance Technologies LLC’s 13F portfolio moves.

Whoisbuyingnow.com will continue tracking congressional disclosures involving MDT and related insider activity as new filings become available, updating this record if further transactions surface within the same reporting window.

Source: original House Periodic Transaction Report.

Leave a Comment